Risk Prediction Models Identify Hodgkin Lymphoma Survivors at Risk for CVD
Researchers sought to determine risk predictors for coronary heart disease and heart failure in Hodgkin lymphoma survivors who were aged 18 to 50 at diagnosis.
Daily Oncology News
Adding Pembrolizumab to CRT Does Not Improve Outcomes in Head and Neck Cancer
Adding pembrolizumab to chemoradiotherapy did not improve event-free survival or overall survival.
ASTRO Offers Guidance on RT for IDH-Mutant Diffuse Grade 2, 3 Glioma
Guideline recommendations support reduction in volume of brain irradiation while attempting to maximize disease control.
Plant-based or Keto: Which Is Optimal for Health, Reduced Cancer Risk in Survivorship?
Researchers at Memorial Sloan Kettering Cancer Center conducted a study to determine which diet is better at reducing cancer risk and improving health: keto or plant-based.
Treatment Sequencing Improves Cost-Effectiveness, Value of Care in Metastatic Breast Cancer
Researchers sought to determine how sequence of first- to third-line treatment of metastatic breast cancer influences cost and value of care.
Fruquintinib Potentially Practice-Changing in Refractory Metastatic Colorectal Cancer
Adding fruquintinib to best supportive care improved progression-free survival and overall survival in the FRESCO-2 trial.
Coagulation Parameters With Cytokine-Release Syndrome and CAR-T Therapy in B-Cell Lymphomas
Researchers sought to determine patterns in coagulation parameters linked to cytokine-release syndrome in patients receiving CAR-T therapy.
Adjuvant Nivolumab + Ipilimumab Lacks Efficacy for Localized RCC
Trial did not meet primary efficacy end point of disease-free survival in patients with localized RCC at high risk for postnephrectomy relapse.
Prognosis Improved After Moderate ICI-Related Colitis Due to Melanoma Treatment
Researchers explored the effects of developing ICI-related colitis on patients treated with ipilimumab as monotherapy and dual therapy for advanced melanoma.
First-Line Atezolizumab Outperforms Chemo in Poor-Prognosis Non-Small Cell Lung Cancer
The 24-month overall survival rate was 24.3% in the atezolizumab arm and 12.4% in the chemotherapy arm.
First-Line Brentuximab Vedotin With AVD Improves Survival in Stage III or IV Hodgkin Lymphoma
Researchers sought to determine whether adding brentuximab vedotin to AVD would improve survival in patients with stage III or IV Hodgkin lymphoma.
Photon-Counting Detector CT Helps ID Multiple Myeloma Lesions
Use of PCD CT images with convolutional neural network denoising improves viewing of pathologic abnormalities, detects lytic lesions.
Oral Care Protocol Eased Severe Oral Mucositis Due to HSCT Conditioning Regimen
Researchers investigated whether bovine colostrum- and Aloe vera-based products would ease severe oral mucositis in patients undergoing hematopoietic stem cell transplantation.
Longer Course of ADT With Postop Radiotherapy Improves Metastasis-Free Survival in Prostate Cancer
Adding a longer course of androgen deprivation therapy to postoperative radiotherapy may prolong metastasis-free survival in patients with prostate cancer.
Belantamab Mafodotin Yields Good Response Rate in Patients With Relapsed, Refractory Multiple Myeloma
Researchers sought to determine whether belantamab mafodotin would be a viable option for treating patients with relapsed/refractory multiple myeloma
Skin Cancer Clinical Trials
Clinical Trial: The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical trial focusing on herditary nonpolyposis colon cancer. The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical Trial: Spectral Diagnosis of Cutaneous Malignancy
Clinical trial focusing on spectral diagnosis. Spectral Diagnosis of Cutaneous Malignancy
Clinical Trial: Electronic Brachytherapy for the Treatment of NMSC
Clinical trial focusing on electronic brachytherapy. Electronic Brachytherapy for the Treatment of NMSC
Clinical Trial: Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical trial focusing on epidermal micrografts. Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical Trial: Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Clinical trial focusing on Mohs surgery project. Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Daily Oncology News
Loading... 
Loading...